Biomedical subjects

Carl W Young

Publications and source records attributed to Carl W Young.

2 recordsLinked to original sources

PubMed2004

Reconstruction of extensive maxillary defects using zygomaticus implants.

PURPOSE: Maxillary reconstruction after maxillectomy remains a great challenge for the reconstructive oral and maxillofacial surgeon. This article is a clinical retrospective analysis of patients reconstructed with zygomaticus implants after maxillary ablation. PATIENTS AND METHODS: The design of the study was a retrospective review of 9 patients requiring near-total or total maxillectomy for pathologic reasons. Clinical records, photographs, and radiographs were studied. Financial billing statements were reviewed to determine charges for implant reconstruction and method of payment. RESULTS: Maxillary reconstruction using zygomaticus and standard endosseous implants was performed in 9 patients. Maxillary resection was performed for the following reasons: salivary gland malignancy (n = 2), squamous cell carcinoma (n = 5), maxillary mucormycosis (n = 1), and extensive maxillary atrophy and infection secondary to subperiosteal maxillary implant placement (n = 1). A total of 28 zygomaticus implants and 10 standard endosseous implants were used to reconstruct the 9 patients. Six zygomaticus implants and 3 standard endosseous implants failed. The time of zygomaticus implant placement ranged from placement at the time of resection to 3.2 years after the resection. Five patients received radiation therapy. Five patients have been reconstructed with a maxillary obturator and have been functioning with the prosthesis for a minimum of 2 years. CONCLUSION: The combination of zygomaticus and standard endosseous implants can be used to reliably reconstruct patients after extensive resection of the maxilla.

Aged↗

PubMed2004

Surrogate markers of health after titanium dental implant placement.

PURPOSE: We investigated the effects of dental implants on patient health, as measured by commonly used surrogates of human homeostasis, including hepatic metabolic and synthetic ability, renal regulatory functions, bone turnover, clotting, infection, and inflammation. MATERIALS AND METHODS: Patients enrolled had 1 to 3 mandibular uncoated, endosseous titanium dental implants placed and restored. Patients were evaluated serially over 6 months. Blood and urine tests were collected immediately before and 6 months after implant placement. Paired student t tests were used to compare quantified laboratory values. Nonquantified values were evaluated using the McNamara chi square analysis to assess patterns of change. RESULTS: Thirty-one patients met the inclusion criteria. A total of 53 dental implants were placed. Three values were found to be significantly different between the 2 time periods: total protein (P < .008), lactate dehydrogenase (P < .002), and hematocrit (P < .017). Total protein and lactate dehydrogenase were within the laboratory range of normal and judged to be clinically nonsignificant. On reevaluation, the significant change in hematocrit was entirely accounted for by a single outlier. This was attributed to laboratory error. CONCLUSION: No clinically significant effects on surrogate markers of health were found 6 months after placement of titanium dental implants. This series is the only one in the dental, craniomaxillofacial, and orthopedic literature showing a lack of adverse human health effects after dental implant placement, as measured by accepted surrogate measures of human homeostasis.

Adult↗